Data / Drug companies / Professional Compounding Centers of America DBA Pcca
Professional Compounding Centers of America DBA Pcca: 487 products in the FDA NDC directory, labeler code 51927
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Professional Compounding Centers of America DBA Pcca (labeler code 51927) lists 487 products in the FDA National Drug Code Directory. By type: 487 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on October 23, 2026.
The request: Watch Professional Compounding Centers of America DBA Pcca (FDA labeler code 51927): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 51927
- Products in commercial distribution
- 487
- Packages
- 487
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule II 16, Schedule III 18, Schedule IV 14, Schedule V 1
- Started marketing in the last 12 months
- 20
- Products with a marketing end date set
- 27
- Earliest marketing start
- May 1, 1996
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients for compounding | 487 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 487 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 476 | 97.7% |
| Liquid | 3 | 0.6% |
| Crystal | 3 | 0.6% |
| Concentrate | 2 | 0.4% |
| Powder, for suspension | 1 | 0.2% |
| Solution | 1 | 0.2% |
| Granule | 1 | 0.2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ibuprofen | 51927-0392 | Powder | Bulk ingredients for compounding | October 23, 2026 |
| Nifedipine | 51927-0391 | Powder | Bulk ingredients for compounding | August 20, 2026 |
| Progesterone | 51927-0389 | Powder | Bulk ingredients for compounding | June 19, 2026 |
| Azelaic acid | 51927-0390 | Powder | Bulk ingredients for compounding | June 17, 2026 |
| Miconazole nitrate | 51927-0388 | Powder | Bulk ingredients for compounding | May 27, 2026 |
| Haloperidol | 51927-0387 | Powder | Bulk ingredients for compounding | March 31, 2026 |
| Ondansetron hydrochloride | 51927-0386 | Powder | Bulk ingredients for compounding | February 25, 2026 |
| Propofol | 51927-4503 | Liquid | Bulk ingredients for compounding | February 17, 2026 |
| Ondansetron hydrochloride | 51927-0385 | Powder | Bulk ingredients for compounding | February 17, 2026 |
| Mercaptopurine | 51927-4500 | Powder | Bulk ingredients for compounding | February 5, 2026 |
| Propofol | 51927-5296 | Powder | Bulk ingredients for compounding | January 30, 2026 |
| Lorazepam | 51927-0384 | Powder | Bulk ingredients for compounding | January 30, 2026 |
| Neomycin sulfate | 51927-0383 | Powder | Bulk ingredients for compounding | January 29, 2026 |
| Dexamethasone | 51927-0382 | Powder | Bulk ingredients for compounding | January 27, 2026 |
| Phytonadione | 51927-5292 | Powder | Bulk ingredients for compounding | December 18, 2025 |
| Heparin sodium | 51927-0381 | Powder | Bulk ingredients for compounding | December 9, 2025 |
| Dexamethasone sodium phosphate | 51927-0380 | Powder | Bulk ingredients for compounding | December 2, 2025 |
| Morphine sulfate | 51927-0379 | Powder | Bulk ingredients for compounding | December 1, 2025 |
| Linezolid | 51927-5293 | Powder | Bulk ingredients for compounding | November 21, 2025 |
| Ergocalciferol | 51927-5291 | Powder | Bulk ingredients for compounding | November 19, 2025 |
| Gabapentin | 51927-0378 | Powder | Bulk ingredients for compounding | October 23, 2025 |
| Chlorhexidine gluconate | 51927-0377 | Solution | Bulk ingredients for compounding | October 22, 2025 |
| Celecoxib | 51927-0376 | Powder | Bulk ingredients for compounding | October 8, 2025 |
| Tetracaine hydrochloride | 51927-0374 | Powder | Bulk ingredients for compounding | September 4, 2025 |
| Voriconazole | 51927-5286 | Powder | Bulk ingredients for compounding | September 3, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.